About Nanion Technologies

Situated in the heart of Munich, Nanion is vibrant team of scientists and engineers with the goal of providing top quality instrumentation and customer service for a broad range of analytical applications. Since it was founded in 2002, Nanion has grown to one of the most respected automated patch clamp providers worldwide. With a focus on ion channels, Nanion is committed to providing our customers with state-of-the-art technological solutions for all aspects of ion channel, transporter research and drug discovery, and has expanded its product range to include extracellular recording techniques. Through our employees we have a wealth of ion channel and electrophysiological expertise and base our technological developments on the needs of our academic and industrial customers. At our headquarters, engineers, scientists, and software developers work closely together under one roof to produce, assemble, improve and test every one of our devices and every batch of consumables that leaves the premises, so that you can be sure of the very best quality. We are a privately owned company, and our profit goes back into development of new and improved products. Our friendly team of experts is waiting to tell you about our products that can revolutionize your research, get in touch today!



Our mission is to provide innovative, high performance instrumentation that enable scientists and researchers to analyze ion channels, electrogenic transporters and excitable cells. Our team of scientists and engineers is committed to constant development and improvement of our products to meet the needs of our customers. Our goal is to provide best-in-class products and customer service to enable worldwide use of our instruments in academic and industrial laboratories to advance scientific discovery and drug development in the fields of safety pharmacology, toxicology and efficacy.


Nanion Technologies GmbH is a privately owned biotechnology company with a growing portfolio of self-developed analytical instruments for electrophysiological research and drug development. Click below to see our major achievements over the years.

Timeline 1 SS

Timeline 2 SS

Timeline 3 SS


Instrument Launches

Planar Patch Clamp Devices:

icon pap   Port-a-Patch,   icon pl   Patchliner and   icon sp96   SyncroPatch 384:

Our first patch clamp device, the Port-a-Patch (the smallest patch clamp rig in the world), was launched in 2003. Building on the success of this instrument, the Patchliner (a fully automated patch clamp platform) was launched in 2006. In 2013 we launched the SyncroPatch 384/768PE which was the first high throughput patch clamp instrument on the market with giga-seal data quality. In 2019 the SyncroPatch 384i was launched building on the succcess of the SyncroPatch 384/768PE. In 2019 we also launched the Port-a-Patch mini, making automated patch clamp even smaller and more affordable. In 2021 we were pleased to take automated patch clamp to new levels with the SyncroPatch 384, the most flexible high throughput automated patch clamp system to date.

Bilayer Recording Devices:

Icon Orbit   Orbit 16 TC,   Icon Orbit Mini   Orbit mini and   icon vpp   Vesicle Prep Pro:

The Vesicle Prep Pro for the formation of giant unilamellar vesicles has been on the market since 2006. In 2012, the Orbit 16 was launched for automated bilayer formation and parallel recordings of 16 channels. In 2014 we introduced the Orbit mini, a 4 channel system that also features temperature control. In 2021, the Orbit 16 TC was introduced as the successor of the Orbit 16, now offering temp control.

SSM Electrophysiology Devices:

Icon 96SE   SURFE²R 96SE and   Icon N1   SURFE²R N1:

In 2012, we acquired the SURFE2R technology for direct functional analysis of electrogenic transporter proteins. Nanion now offers the SURFE2R N1 and has recently developed and launched (2017) a high throughput platform based on this technology, the SURFE2R 96SE – the SURF Engine!

Extracellular Recording Devices:

Icon CE   CardioExcyte 96 and FLEXcyte 96:

In 2014, we launched the CardioExcyte 96, equipped with contractility and field potential technology, to analyze iPSC-derived cardiomyocyte networks for drug safety assessment. It also enables cell monitoring for cell viability assays on a diverse range of cells types (e. g. hepatocytes) for toxicity screening. In 2019 we launched the FlexCyte 96 in collaboration with our partners, InnoVitro, for cardiac contraction force measurements.



Nanion Technologies was founded in 2002 as a spin-off from the University of Munich, Center for Nanoscience (CeNS), where Niels Fertig undertook his PhD developing planar chip substrates for patch clamp experiments on cells and lipid bilayers. That work led to the possibility for automation and parallelization of patch clamp experiments and towards the end of his PhD, Niels co-founded the company with the goal to make automated electrophysiology a readily available technology.


Nanion management team (left to right) Niels Fertig, Andrea Brüggemann and Michael George
(image copyright Ansger Pudenz Deutscher Zukunftspreis 2014)

Nanion started with just two employees, Niels Fertig and Michael George, and the management team was completed in the second year, when Andrea Brüggemann joined. All three are physicists by training and share a healthy mix of expertise in ion channel biophysics, tech development and cell based assays together with being market driven and entrepreneurial in spirit.

Over the last 19 years, Nanion has grown to a company with almost 100 employees worldwide, at the beginning offering just one product, the Port-a-Patch, which now has increased to nine product families for all aspects of ion channel research and drug discovery, safety pharmacology, bilayer measurements and transporter research.

With the introduction of the SyncroPatch 384/768PE in 2013, Nanion entered the HTS ion channel screening market and has become the preferred choice for automated electrophysiology laboratories worldwide (HTS Tech report 2015).

img Keimzelle

From left to right: Michael George (CTO), Prof. Jan Behrends (Chairman of the board), Andrea Brüggemann (CSO), Prof. Hermann Gaub (Co-founder), Niels Fertig (CEO), Prof. Jörg Kotthaus (Co-founder)

Nanion operates globally from its headquarters in Munich, Germany, and has daughter companies in the USA, China, and Japan, with distribution partners in 5 other countries. Nanion recently moved into new headquarters in Munich’s city center, with excellent laboratories and production facilities. The above photo was taken at the house-warming party and shows the management team and all co-founders.

Team Spirit is our Success

Our team spirit, developed through jointly working on and solving challenging interdisciplinary tasks, has fueled a responsibility for the company and each other, as well as deep friendships among the team. We learned how to listen carefully to our clients and partners: Customer feedback and scientific discoveries have always been the most important source for our product development projects. For over 15 years, our scientists have worked closely together with our engineers and software developers and we continue to create new features for our existing product platforms and develop new analytical tools and instrumentation.  


We are passionate about our work: We develop smart analysis tools which meet the demands and requests of our clients.


 Service AssayDevelopment 330


Back to Overview

We use cookies on our website. Some of them are essential for the operation of the site, while others help us to improve this site and the user experience (tracking cookies). You can decide for yourself whether you want to allow cookies or not. Please note that if you reject them, you may not be able to use all the functionalities of the site.